INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 442m ago
HOUSE PTR42m ago
SEC 13F41m ago
ROBINHOOD CHAIN41m ago
Public company

VRCAVerrica Pharmaceuticals Inc.

CIK 0001660334

EDGAR filingsOpen in network
Disclosed transactions11
Buys / sells7 / 0
Max Insider Score52
Connections5with evidence

VRCA · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
37
RJ
Rieger JaysonDirector, CEO and President
VRCAVerrica Pharmaceuticals Inc.
Open-market purchase
BUY$101K
20.0K sh
Aug 14, 2026Aug 18, 2026
traded Aug 14, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Eichenfield LawrenceDirector · Jun 9, 2026
  • ← Insider ofevidence
    Nguyen DiemDirector · Jun 9, 2026
  • ← Insider ofevidence
    Zawitz DavidChief Operating Officer · Nov 25, 2025
38
ZD
Zawitz DavidChief Operating Officer
VRCAVerrica Pharmaceuticals Inc.
Open-market purchase
BUY
$30K
6,000 sh
Aug 17, 2026
Aug 18, 2026
traded Aug 17, 2026
+1d
SEC FORM 4

Evidence

30
RJ
Rieger JaysonDirector, CEO and President
VRCAVerrica Pharmaceuticals Inc.
Open-market purchase
BUY$25K
5,000 sh
Aug 17, 2026Aug 18, 2026
traded Aug 17, 2026
+1dSEC FORM 4

Evidence

9
ND
Nguyen DiemDirector
VRCAVerrica Pharmaceuticals Inc.
Grant or award
A—
16.0K sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC FORM 4

Evidence

5
ZD
Zawitz DavidChief Operating Officer
VRCAVerrica Pharmaceuticals Inc.
Grant or award
A—
171.3K sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC FORM 4

Evidence

5
RJ
Rieger JaysonDirector, CEO and President
VRCAVerrica Pharmaceuticals Inc.
Grant or award
A—
512.3K sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC FORM 4

Evidence

9
EL
Eichenfield LawrenceDirector
VRCAVerrica Pharmaceuticals Inc.
Grant or award
A—
16.0K sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC FORM 4

Evidence

52
RJ
Rieger JaysonDirector, CEO and President
VRCAVerrica Pharmaceuticals Inc.
Open-market purchase
BUY$400K
94.3K sh
Nov 25, 2025Nov 25, 2025
traded Nov 25, 2025
+0dSEC FORM 4

Evidence

46
RJ
Rieger JaysonDirector, CEO and President
VRCAVerrica Pharmaceuticals Inc.
Open-market purchase
BUY—
23.6K sh
Nov 25, 2025Nov 25, 2025
traded Nov 25, 2025
+0dSEC FORM 4

Evidence

46
ZD
Zawitz DavidChief Operating Officer
VRCAVerrica Pharmaceuticals Inc.
Open-market purchase
BUY—
2,500 sh
Nov 25, 2025Nov 25, 2025
traded Nov 25, 2025
+0dSEC FORM 4

Evidence

46
ZD
Zawitz DavidChief Operating Officer
VRCAVerrica Pharmaceuticals Inc.
Open-market purchase
BUY$42K
10.0K sh
Nov 25, 2025Nov 25, 2025
traded Nov 25, 2025
+0dSEC FORM 4

Evidence

← Insider ofevidence
Rieger Jayson
Director, CEO and President · Nov 25, 2025